Control Bionics Limited (ASX:CBL)

Control Bionics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 5, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	14	9	10	8	20	58
Market Cap Growth	28.14%	-14.71%	31.65%	-59.75%	-66.31%	-
Enterprise Value	14	8	9	5	12	57
Last Close Price	0.04	0.03	0.05	0.08	0.20	0.62
PS Ratio	2.24	1.44	1.94	1.40	4.34	14.20
PB Ratio	2.50	1.60	1.65	1.10	1.64	3.38
P/TBV Ratio	8.44	5.41	4.67	2.59	2.49	4.44
EV/Sales Ratio	2.21	1.35	1.71	0.89	2.56	13.92
Debt / Equity Ratio	0.08	0.08	0.15	0.02	0.02	0.00
Asset Turnover	0.71	0.71	0.60	0.51	0.28	0.33
Inventory Turnover	4.99	4.99	2.41	2.24	3.34	6.37
Quick Ratio	1.00	1.00	1.32	1.75	4.96	11.47
Current Ratio	1.24	1.24	1.57	2.49	6.33	11.69
Return on Equity (ROE)	-103.74%	-103.74%	-88.16%	-59.05%	-41.95%	-31.03%
Return on Assets (ROA)	-43.14%	-43.14%	-40.69%	-29.53%	-24.29%	-15.93%
Return on Capital (ROIC)	-56.53%	-56.53%	-49.81%	-33.58%	-26.27%	-16.98%
Earnings Yield	-44.30%	-69.12%	-57.07%	-71.54%	-31.20%	-6.12%
FCF Yield	-33.15%	-51.73%	-51.24%	-62.96%	-35.97%	-6.96%
Buyback Yield / Dilution	-65.68%	-65.68%	-76.64%	-5.80%	-36.04%	-535.65%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.